AdvanSix Inc. (New York Stock Exchange:ASIX)
| Market Cap | 450.22M-19.2% |
| Revenue (ttm) | 1.56B+3.0% |
| Net Income | -17.73M-122.9% |
| EPS | -0.66-123.2% |
| Shares Out | 26.96M |
| PE Ratio | n/a |
| Forward PE | 7.00 |
| Dividend | $0.64(3.83%) |
| Ex-Dividend Date | Aug 18, 2026 |
| Volume | 266,069 |
| Open | 16.64 |
| Previous Close | 16.64 |
| Day's Range | 16.61 - 16.89 |
| 52-Week Range | 14.10 - 26.73 |
| Beta | 1.34 |
| Analysts | Buy |
| Price Target | 30.80(+84.43%) |
| Earnings Date | Nov 4, 2026 |
Insiders here have filed 1 Form 4 in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
About ASIX
AdvanSix Inc. operates as a global manufacturer and supplier of polymer resins, serving markets across the United States and internationally. A key offering is Nylon 6, a versatile synthetic polymer resin utilized in the production of fibers, filaments, specialized plastics, and films. The company's portfolio also includes caprolactam, an essential building block for other polymer resins, and ammonium sulfate fertilizers, which it distributes to farm cooperatives, retailers, and other channel partners. Furthermore, AdvanSix supplies acetone, a crucial ingredient for manufacturing adhesives, paints, coatings, solvents, herbicides, and engineered plastic resins. Its extensive range additionally comprises various intermediate chemicals, such as phenol, alpha-methyl styrene, cyclohexanone, methyl ethyl ketoxime, acetaldehyde oxime, 2-pentanone oxime, cyclohexanol, sulfuric acid, ammonia, and carbon dioxide. These offerings are marketed under established brands like Aegis, Capra, Sulf-N, Nadone, Naxol, and EZ-Blox. AdvanSix utilizes a dual sales approach, engaging directly with customers while also leveraging a network of distributors. The company, established in 2016, is headquartered in Parsippany, New Jersey.
$ASIX stock is featured in our Insider Trades datasets.
→ All Stock ListsRecently reported changes in ASIX holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by ASIX's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
ASIX Estimated quarterly lobbying spending
Source: U.S. Senate LDA
ASIX Revenue by Segment or Geography
| Segment | Revenue | % of All |
|---|---|---|
| Plant Nutrients | $131.44M | 31.20% |
| Chemical Intermediates | $126.98M | 30.14% |
| Nylon | $100.22M | 23.79% |
| Caprolactam | $62.64M | 14.87% |
As of: Q2 2026 (Jun 30, 2026) · Source: SEC EDGAR (10-Q)
U.S. Patents
New ASIX patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to ASIX from public contracts
Source: USAspending.gov
Top ETF Holders
ETFs with the largest estimated holdings in ASIX
| ETF | Est. Holding Size |
|---|---|
| AVUVAvantis U.S. Small Cap Value ETF | $22.13M |
| VTIVanguard Morningstar Total Stock Market ETF | $13.71M |
| IWMiShares Russell 2000 ETF | $11.89M |
| DFSVU.S. Small Cap Value Portfolio ETF Class Shares | $8.71M |
| VXFVanguard Extended Market ETF | $5.27M |
| DFATDimensional - US Targeted Value ETF | $4.72M |
Estimated from each fund’s disclosed top holdings × AUM
ASIX Insider Score
Our composite score: insider buying, sector, volume, tone & dilution
Bull Case vs Bear Case
AI-generated from ASIX’s recent data — informational, not investment advice
